KalVista Pharmaceuticals
KALV
#6541
Rank
$0.53 B
Marketcap
$10.71
Share price
-5.39%
Change (1 day)
-4.46%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2025 (TTM): -$0.18 Billion USD

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$0.18 Billion USD a decrease over its 2023 earnings that were of -$0.12 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.18 Billion0%
2024 -$0.18 Billion43.36%
2023 -$0.12 Billion12.87%
2022 -$0.11 Billion20.62%
2021 -$87.85 Million79.87%
2020 -$48.84 Million14.01%
2019 -$42.84 Million98.95%
2018 -$21.54 Million3.41%
2017 -$20.83 Million-13.11%
2016 -$23.97 Million1.3%
2015 -$23.66 Million92.7%
2014 -$12.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.15 Billion-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA